TISSUE CROSS-REACTIVITY STUDY OF A HUMAN ANTIBODY

$1.08M USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Sri International
Country	United States
Start Date	Apr 09, 2021
End Date	Apr 08, 2022
Duration	364 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10474740`

Grant Description

The test agent is being considered for development as an anticancer therapeutic. The objective of this task was to obtain a source of tissue or cells for in vitro evaluations of toxicity. The information obtained from this investigation was used to identify drugs with the potential to treat cancer.